Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | AAN7QOV9EA |
InChI Key | JAZBEHYOTPTENJ-JLNKQSITSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value | |
---|---|---|
Molecular Formula | C20H30O2 | |
Molecular Weight | 302.46 | |
AlogP | 5.99 | |
Hydrogen Bond Acceptor | 1.0 | |
Hydrogen Bond Donor | 1.0 | |
Number of Rotational Bond | 13.0 | |
Polar Surface Area | 37.3 | |
Molecular species | ACID | |
Aromatic Rings | 0.0 | |
Heavy Atoms | 22.0 |
Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
---|---|---|---|---|---|
Depressive Disorder | 3 | D003866 | ClinicalTrials | ||
Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials | ||
Hypertriglyceridemia | 3 | D015228 | ClinicalTrials | ||
Coronary Disease | 3 | D003327 | ClinicalTrials | ||
Adenomatous Polyposis Coli | 3 | D011125 | ClinicalTrials | ||
Heart Failure | 3 | D006333 | ClinicalTrials | ||
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials | ||
Cardiovascular Diseases | 3 | D002318 | ClinicalTrials | ||
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials | ||
Cholestasis | 3 | D002779 | ClinicalTrials | ||
Obesity | 3 | D009765 | ClinicalTrials | ||
Intestinal Diseases | 3 | D007410 | ClinicalTrials | ||
Cachexia | 3 | D002100 | ClinicalTrials | ||
Glomerulonephritis, IGA | 3 | D005922 | ClinicalTrials | ||
Anorexia | 3 | D000855 | ClinicalTrials | ||
Psychotic Disorders | 2 | D011618 | ClinicalTrials | ||
Breast Neoplasms, Male | 2 | D018567 | ClinicalTrials | ||
Phobia, Social | 2 | D000072861 | ClinicalTrials | ||
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials | ||
Fatty Liver | 2 | D005234 | ClinicalTrials | ||
Inflammation | 2 | D007249 | ClinicalTrials | ||
Carcinoma, Lobular | 2 | D018275 | ClinicalTrials | ||
Carcinoma, Intraductal, Noninfiltrating | 2 | D002285 | ClinicalTrials | ||
Lymphoma, Follicular | 2 | D008224 | ClinicalTrials | ||
Schizophrenia | 2 | D012559 | ClinicalTrials | ||
Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials | ||
Asthma | 2 | D001249 | ClinicalTrials | ||
Bipolar Disorder | 2 | D001714 | ClinicalTrials | ||
Neoplasms | 2 | D009369 | ClinicalTrials | ||
Epilepsy | 2 | D004827 | ClinicalTrials | ||
Liver Diseases | 2 | D008107 | ClinicalTrials | ||
Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials | ||
Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials | ||
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials | ||
Multiple Sclerosis | 2 | D009103 | ClinicalTrials | ||
Substance-Related Disorders | 2 | D019966 | ClinicalTrials | ||
Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials | ||
Adenoma | 2 | D000236 | ClinicalTrials | ||
Breast Neoplasms | 2 | D001943 | ClinicalTrials | ||
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials | ||
Brain Concussion | 2 | D001924 | ClinicalTrials | ||
Multiple Myeloma | 1 | D009101 | ClinicalTrials | ||
Feeding and Eating Disorders | 1 | D001068 | ClinicalTrials | ||
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials | ||
Aging | 1 | D000375 | ClinicalTrials | ||
Leukemia | 1 | D007938 | ClinicalTrials | ||
Kidney Diseases | 0 | D007674 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 28364 |
ChEMBL | CHEMBL460026 |
DrugBank | DB00159 |
DrugCentral | 3174 |
EPA CompTox | DTXSID9041023 |
FDA SRS | AAN7QOV9EA |
Human Metabolome Database | HMDB0001999 |
Guide to Pharmacology | 3362 |
KEGG | C06428 |
PDB | EPA |
PharmGKB | PA164746077 |
SureChEMBL | SCHEMBL20469 |
ZINC | ZINC000004474603 |